e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Early diagnosis and prevention in children with atopy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical benefits and safety of long term treatment with Montelukast in children with asthma
D. A. Plesca, D. Dragomir (Bucharest, Romania)
Source:
Annual Congress 2002 - Early diagnosis and prevention in children with atopy
Session:
Early diagnosis and prevention in children with atopy
Session type:
Thematic Poster Session
Number:
3266
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. A. Plesca, D. Dragomir (Bucharest, Romania). Clinical benefits and safety of long term treatment with Montelukast in children with asthma. Eur Respir J 2002; 20: Suppl. 38, 3266
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Clinical benefits and safety of long term treatment with montelukast (M) in patients with mild-to-moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001
Long term efficacy and safety of omalizumab in patients with allergic asthma-A real life study
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
Long-term treatment of aspirin-intolerante asthma with budesonide. Effectivity and safety
Source: Eur Respir J 2001; 18: Suppl. 33, 156s
Year: 2001
Safety of formoterol in children and adolescents: experience from asthma clinical trials
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Efficacy of the long-term therapy with simbicort in children with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005
Can Internet-based management improve asthma control? A long term randomised clinical study of 300 asthmatics
Source: Eur Respir J 2005; 26: Suppl. 49, 44s
Year: 2005
Omalizumab improves asthma in long term therapy
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008
Fluticasone propionate in asthmatic children: a long term dose comparison of safety and efficacy
Source: Eur Respir J 2001; 18: Suppl. 33, 288s
Year: 2001
Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial
Source: Eur Respir J 2003; 22: 787-794
Year: 2003
Safety and efficacy of omalizumab in children with allergic asthma
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
Country-specific cost-effectiveness of early intervention with budesonide in mild asthma
Source: Eur Respir J 2004; 24 : 568-574
Year: 2004
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Clinical efficacy of new non-freon aerosol troventol in asthma patients
Source: Annual Congress 2006 - Recent advances in asthma treatment
Year: 2006
Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Longterm safety study of FlutiFormÔ HFA in asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept